July 22, 2026
Breakthrough T1D Applauds the U.S. Senate Committee on Health, Education, Labor, and Pensions for Voting to Approve INSULIN Act
July 15, 2026
Breakthrough T1D CEO Aaron Kowalski Testifies Before U.S. House of Representatives’ Committee on Energy and Commerce
July 7, 2026
Breakthrough T1D Awards Grant to Support PRISE‑hATG Study of SAB‑142 in Stage 3 Type 1 Diabetes
June 23, 2026
MannKind Awarded Breakthrough T1D Grant to Support Advancement of INHALE-1ST Pediatric Trial of Afrezza® in Youth with Newly-Diagnosed T1D
June 15, 2026
Breakthrough T1D Presents New Jersey Resident Gina Gehan with the 2025 Huntsman Family Community Engagement Award
June 12, 2026
Breakthrough T1D Celebrates Approval of Tzield for use in Stage 3 Type 1 Diabetes in the US
June 8, 2026
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine
June 2, 2026
Breakthrough T1D and Sub-Zero Group Foundation Announce National Partnership to Support Type 1 Diabetes Research
May 29, 2026
Breakthrough T1D Celebrates FDA Approval of Afrezza for Use in Children and Adolescents With Type 1 Diabetes
May 22, 2026
Breakthrough T1D Supports Bipartisan SCREEN for T1D Act Introduced by U.S. Representatives Schrier and Joyce and Senators Shaheen and Collins
